Navigation Links
'Non-invasive' cultivar? Buyer beware
Date:10/6/2011

Cultivars of popular ornamental woody plants that are being sold in the United States as non-invasive are probably anything but, according to an analysis by botanical researchers published in the October issue of BioScience. Tiffany M. Knight of Washington University in St. Louis, Missouri, and her coauthors at the Chicago Botanic Garden write that the claims of environmental safety are in most cases based on misleading demographic evidence that greatly underestimates the plants' invasive potential. What is more, the offspring of cultivars do not usually "breed true" and may be more fecund than their parents, especially if they cross with plants from nearby feral populations.

Many invasive plants were once ornamental cultivars, because the characteristics that the "green" industry looks for are the same ones that make a plant potentially invasive -- being adaptable to wide range of conditions, forming dense stands good for erosion control, and having a long flowering period, for example. In recent years the nursery and horticultural industries have responded by creating cultivars of top-selling plants that produce reduced numbers of viable seed and are advertized as "safe to natural areas." Such cultivars of Japanese barberry, buckthorn, and burning bush are now widely sold, as they avoid bans on growing invasive species.

Yet simple population modeling demonstrates that reductions of even 95 percent in the number of viable seed will leave a long-lived species quite capable of spreading -- and many of the new cultivars do not achieve even that much of a reduction. More sophisticated modeling would likely reveal even stronger invasive potential of the "safe" cultivars. Knight and her co-authors conclude that only completely sterile cultivars can be considered truly safe without further testing, and that other types should be tested for breeding true and having a low growth rate before they are sold as non-invasive.


'/>"/>
Contact: Tim Beardsley
tbeardsley@aibs.org
703-654-2500 x326
American Institute of Biological Sciences
Source:Eurekalert

Page: 1

Related biology news :

1. Potential for non-invasive brain tumor treatment
2. Buyer beware: Dangerous levels of lead found in used consumer products
3. Amphibians: Beware young beetles deadly siren call
4. Beware of predatory male black bears
5. Coffee, energy drinkers beware: Many mega-sized drinks loaded with sugar, MU nutrition expert says
6. Urban gardeners beware: There may be lead in your soil and food
7. NASA scientist publishes new book: Coming Climate Crisis? Consider the Past, Beware the Big Fix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: